We hypothesized that FASN was the key downstream effector of the bidirectional ER/HER2 crosstalk that promotes malignant phenotypes, such as proliferation, migration, apoptosis evasion and endocrine resistance, in ER+/HER2+ breast cancer cells. Here, ESR1 is linked to breast cancer.